• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.23% Nasdaq Down 1.88%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    90.05 Down 1.89(2.06%) 10:11AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:91.94
    Open:89.79
    Bid:90.05 x 700
    Ask:90.40 x 200
    1y Target Est:116.25
    Beta:0.053454
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:88.99 - 91.19
    52wk Range:41.99 - 112.40
    Volume:40,084
    Avg Vol (3m):425,162
    Market Cap:1.79B
    P/E (ttm):58.06
    EPS (ttm):1.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 2.06%1.79B
    MRKDown 2.27%148.24B
    LLYDown 2.47%85.06B

    Key Statistics

    Forward P/E (1 yr):28.97
    P/S (ttm):25.71
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.86
    Quarterly EPS Est (Sep-15) :0.42
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.72

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback